Drugs / Equine collagen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT01681030 Comparator | Aug 2012 → Aug 2013 | cardiovascular disorder | Ethicon, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02040428 Comparator | Jan 2014 → Jul 2015 | cardiovascular disorder | Ethicon, Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Equine collagen | “Equine collagen with Human Fibrinogen and Human Thrombin” NCT01681030 ↗1“Equine collagen with Human Fibrinogen and Human Thrombin” NCT02040428 ↗ |
| Modality | Protein / enzyme biologic | “Equine collagen with Human Fibrinogen and Human Thrombin” NCT02040428 ↗ |